T2 Biosystems Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million
29 sept. 2022 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Announces Commercial Expansion Through Distributor in Baltic Region
22 sept. 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced...
T2 Biosystems to Participate in the H.C. Wainwright Global Investment Conference
08 sept. 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
18 août 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Second Quarter 2022 Financial Results
15 août 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox Virus
09 août 2022 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Reports Granting of Inducement Awards
29 juil. 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards...
T2 Biosystems to Report Second Quarter 2022 Financial Results on August 15, 2022
28 juil. 2022 16h32 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference
27 juil. 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel
11 juil. 2022 08h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the...